{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:05:03Z","timestamp":1791914703699,"version":"4.3.4"},"reference-count":42,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1136\/jnnp-2014-308764","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T08:08:06Z","timestamp":1410854886000},"page":"767-773","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":119,"title":["Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"86","author":[{"given":"Gennaro","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pasqualetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia Daniela","family":"Femminella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Monzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tagliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,9,15]]},"reference":[{"key":"key-10.1136\/jnnp-2014-308764-1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson's disease","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"key":"key-10.1136\/jnnp-2014-308764-2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-308764-4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11910-012-0290-7","article-title":"Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia","volume":"12","author":"Aarsland","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.1136\/jnnp-2014-308764-5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2011.01.003","article-title":"Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study","volume":"17","author":"Winter","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2014-308764-6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0278-5846(98)00006-2","article-title":"Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease","volume":"22","author":"Ohara","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","article-title":"A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance","volume":"5","author":"Calabresi","year":"2006","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-308764-8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0404.1984.tb00798.x","article-title":"The basal nucleus of Meynert in idiopathic Parkinson's disease","volume":"70","author":"Tagliavini","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"key-10.1136\/jnnp-2014-308764-9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.20266","article-title":"Prevalence of gait disorders in hospitalized neurological patients","volume":"20","author":"Stolze","year":"2005","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308764-11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/gerona\/glq115","article-title":"Cognition and the risk of hospitalization for serious falls in the elderly: results from the Cardiovascular Health Study","volume":"65","author":"Welmerink","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key-10.1136\/jnnp-2014-308764-12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5114\/ninp.2013.38223","article-title":"The incidence and risk factors of falls in Parkinson disease: prospective study","volume":"47","author":"Rudzi\u0144ska","year":"2013","journal-title":"Neurol Neurochir Pol"},{"key":"key-10.1136\/jnnp-2014-308764-13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"issue":"(Suppl 3)","key":"key-10.1136\/jnnp-2014-308764-14","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308764-15","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2014-308764-16","first-page":"CD006504","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease","volume":"3","author":"Rolinski","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/jnnp-2014-308764-17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","article-title":"Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease","volume":"75","author":"Chung","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308764-18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","article-title":"Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study","volume":"18","author":"Burn","year":"2003","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308764-20","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308764-21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"key-10.1136\/jnnp-2014-308764-22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/jnnp-2014-308764-23","doi-asserted-by":"crossref","first-page":"e52952","DOI":"10.1371\/journal.pone.0052952","article-title":"Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis","volume":"8","author":"Rengo","year":"2013","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2014-308764-24","unstructured":"Higgins JPT, Green S . Cochrane Handbook for Systematic Reviews of Interventions. version 5.1.0 (updated March 2011). http:\/\/www.cochrane\u2013handbook.org The Cochrane Collaboration"},{"key":"key-10.1136\/jnnp-2014-308764-25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2014-308764-26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2014-308764-27","doi-asserted-by":"crossref","DOI":"10.1002\/0470854200","volume-title":"Meta-analysis of controlled clinical trials","author":"Whitehead","year":"2002"},{"key":"key-10.1136\/jnnp-2014-308764-28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key-10.1136\/jnnp-2014-308764-29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2014-308764-30","first-page":"15","article-title":"Assessing the influence of a single study in meta-analysis","volume":"47","author":"Tobias","year":"1999","journal-title":"Stata Tech Bull"},{"key":"key-10.1136\/jnnp-2014-308764-31","first-page":"16","article-title":"Meta-analysis regression","volume":"42","author":"Sharp","year":"1998","journal-title":"Stata Tech Bull"},{"key":"key-10.1136\/jnnp-2014-308764-32","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"key-10.1136\/jnnp-2014-308764-33","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2014-308764-34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","article-title":"Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","volume":"76","author":"Ravina","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-35","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","article-title":"Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","volume":"27","author":"Dubois","year":"2012","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308764-36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(86)91401-0","article-title":"Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease","volume":"362","author":"Ruberg","year":"1986","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2014-308764-37","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson's disease. Functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308764-38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2014-308764-39","volume-title":"A randomized, doubleblind, placebo controlled, crossover study to evaluate the effect of donepezil on gait and balance in Parkinson's disease. Fox Trial Finder [internet]","author":"Oregon Health and Science University","year":"2011"},{"key":"key-10.1136\/jnnp-2014-308764-40","volume-title":"Phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen. Fox Trial Finder [internet]","author":"Whone","year":"2011"},{"key":"key-10.1136\/jnnp-2014-308764-41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/gps.2384","article-title":"A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors","volume":"25","author":"Jones","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308764-42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00002018-200831010-00007","article-title":"Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension","volume":"31","author":"Oertel","year":"2008","journal-title":"Drug Saf"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-308764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T14:50:32Z","timestamp":1717339832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-308764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,15]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,12]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/jnnp-2014-308764"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-308764","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,15]]}}}